These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1679947)

  • 21. Elevation of cyclic 3'5' adenosine monophosphate levels by cholera toxin inhibits the generation of interleukin 2 activity.
    Iwaz J; Lafont S; Revillard JP
    Cell Immunol; 1986 Dec; 103(2):455-61. PubMed ID: 3026658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell receptor-independent CD2 signal transduction in FcR+ cells.
    Arulanandam AR; Koyasu S; Reinherz EL
    J Exp Med; 1991 Apr; 173(4):859-68. PubMed ID: 1706751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The stimulation of T cells with anti-CD2 monoclonal antibodies facilitates the induction of polyclonal B-cell responses but does not enhance the activation of antigen-specific B cells.
    Trifiletti R; Hyman B; LaVia M; Knapp W; Virella G
    Scand J Immunol; 1990 Jan; 31(1):25-31. PubMed ID: 1689073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.
    Anderson DL; Tsoukas CD
    J Immunol; 1989 Dec; 143(11):3647-52. PubMed ID: 2555413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.
    Moingeon P; Lucich JL; McConkey DJ; Letourneur F; Malissen B; Kochan J; Chang HC; Rodewald HR; Reinherz EL
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1492-6. PubMed ID: 1346934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel subset of CD2-, CD3/T cell receptor alpha/beta+ human peripheral blood T cells. Phenotypic and functional characterization of interleukin 2-dependent CD2-CD3+ T cell clones.
    Kabelitz D; Conradt P; Schondelmaier S; Wagner H; Haars R
    J Exp Med; 1989 Aug; 170(2):559-69. PubMed ID: 2569027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of interleukin-4 production in human mononuclear cells.
    Holter W; Majdic O; Kalthoff FS; Knapp W
    Eur J Immunol; 1992 Oct; 22(10):2765-7. PubMed ID: 1356786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulatory effect of aggregating the CD3 molecular complex on T cell activation.
    Gur H; Wacholtz MC; Davis LS; Geppert TD; Lipsky PE
    Cell Immunol; 1992 Mar; 140(1):81-96. PubMed ID: 1531456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase C.
    Ioannides CG; Freedman RS; Liskamp RM; Ward NE; O'Brian CA
    Cell Immunol; 1990 Nov; 131(1):242-52. PubMed ID: 2121373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of interleukin 2 release from a primate lymphoid cell line in serum-free and serum-containing media.
    Brown RL; Griffith RL; Ruscetti FW; Rabin H
    Cell Immunol; 1985 Apr; 92(1):14-21. PubMed ID: 3935331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of human T cells with the physiological regulator of protein kinase C.
    Subramaniam A; Sehajpal P; Murthi VK; Stenzel KH; Suthanthiran M
    Cell Immunol; 1988 Oct; 116(2):439-49. PubMed ID: 2902930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-independent pathways of T-cell activation are functional in human immature thymocytes.
    Poggi A; Zocchi MR
    Int J Clin Lab Res; 1992; 21(4):304-9. PubMed ID: 1375518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation.
    Lorré K; Van Damme J; Verwilghen J; Baroja ML; Ceuppens JL
    J Immunol; 1990 Jun; 144(12):4681-7. PubMed ID: 1972166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of 3'5' cyclic adenosine monophosphate alters CD3 and CD25 antigens expression in activated T lymphocytes.
    Iwaz J; Lafont S; Cordier G; Revillard JP
    J Clin Lab Immunol; 1989 Jun; 29(2):85-9. PubMed ID: 2561159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accessory cell-dependent T-cell activation via Ti-CD3. Involvement of CD2-LFA-3 interactions.
    Halvorsen R; Leivestad T; Gaudernack G; Thorsby E
    Scand J Immunol; 1988 Sep; 28(3):277-84. PubMed ID: 2461580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of interleukin 2 production in the gibbon ape T cell line MLA 144.
    Lin Y; Robb RJ
    Lymphokine Res; 1985; 4(1):1-4. PubMed ID: 3872383
    [No Abstract]   [Full Text] [Related]  

  • 37. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM; Sung SS; Hansen JA; Fu SM
    Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.
    Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD
    J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.
    Vercammen C; Ceuppens JL
    Cell Immunol; 1987 Jan; 104(1):24-36. PubMed ID: 2948675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age- and strain-related differences in murine spleen cell responses to different activation signals.
    Kariv I; Ferguson FG; Confer FL
    Cell Immunol; 1992 Mar; 140(1):67-80. PubMed ID: 1531455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.